Medicare spending on drugs with accelerated approval

24 May 2022 - The U.S. FDA provides accelerated approval to drugs on the basis of surrogate end points deemed to ...

Read more →

Prioritising reference products over biosimilars led to millions of missed savings for Part D

20 April 2022 - Medicare Part D plans missed out on between $84 million and $143 million in savings by ...

Read more →

Budget 2022-23 – no ‘big bang’ announcements in health

29 March 2022 - Medicines Australia welcomes tonight’s Budget announcements for new PBS listings and on-going COVID-19 measures. ...

Read more →

Record investment in the future of Australia's health system

29 March 2022 - The Australian Government is investing in a stronger health system as part of our plan for a ...

Read more →

Final reconciliation of savings from side agreements for the full year 2021

18 March 2022 - TLV has presented the final reconciliation to the government of the outcome of the rebates in ...

Read more →

Stabilising health care’s share of the GDP

19 February 2022 - Since the 1980s, policy makers and private health insurers have implemented various interventions aimed at “bending the ...

Read more →

PBS expenditure and prescriptions report 2020-21

24 December 2021 - The PBS Expenditure and Prescriptions Report 1 July 2020 to 30 June 2021 is now available. ...

Read more →

Recent trends in Medicaid spending and use of drugs with US Food and Drug Administration accelerated approval

8 October 2021 - In this cross-sectional study of 216 drugs granted accelerated approval from 1992 through 2020, relative to all ...

Read more →

House report: drug companies spent more on buybacks, dividends than research

8 July 2021 - House Democrats on Thursday released a report that found that the 14 leading drug companies paid ...

Read more →

New drug could cost the Government as much as it spends on NASA

22 June 2021 - The Alzheimer’s treatment will cost $56,000 per patient, and millions may use it. The result: “crazy numbers” ...

Read more →

Sweden's cost of medicines is increasing

15 June 2021 - Sweden's costs for pharmaceuticals have risen by approximately SEK 2 billion between 2019 and 2020.  ...

Read more →

Protest calls for more drug spending

9 May 2021 - Patients’ rights advocates will lie down on the job, as part of a nationwide day of ...

Read more →

High cost patented drugs now account for 50% of sales

25 March 2021 - Federal Minister of Health tables the 2019 Annual Report of the Patented Medicine Prices Review Board ...

Read more →

PHARMAC saving money at the expense of Kiwis' health

11 March 2021 - Peter Davis’ observations regarding PHARMAC funding new drugs every time there is a change of government ...

Read more →

TLV is tasked with reducing costs for medicines

16 February 2021 - The Government has commissioned the Swedish Dental and Pharmaceutical Benefits Agency, TLV, to implement measures to reduce ...

Read more →